Title : Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass.

Pub. Date : 2010 Jul

PMID : 19798460






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: All arzoxifene doses significantly reduced osteocalcin (primary endpoint), type 1 collagen C-telopeptide, bone specific alkaline phosphatase, and procollagen type I amino-terminal propeptide versus placebo, and increased lumbar spine BMD. LY 353381 bone gamma-carboxyglutamate protein Homo sapiens